The North America Colorectal Cancer Screening Market would witness market growth of 4.2% CAGR during the forecast period (2023-2030).
Due to technological advancements in biotech, favorable policies and the affordability of DNA sequencing will further assure market growth. The FDA recently approved a faecal DNA test and a blood test to detect colorectal cancer to address market requirements for minimally intrusive diagnosis. Improvements in industrial genetics have enabled DNA sequencing with elevated speeds and at affordable costs, increasing the adoption rate for in-vitro colorectal cancer screening tests, thus widening the market prospects. Research and development activities focusing on developing superior DNA sequencing techniques, like RNA polymerase (RNAP) sequencing, microfluidic Sanger sequencing, and hybridization, will substantially affect the growth of this market.
The trend towards personalized medicine has led to the development of screening methods that consider individual risk factors, tailoring screening recommendations based on factors such as family history and genetics. Personalized medicine in the context of colorectal cancer screening involves tailoring screening strategies and interventions based on an individual's unique risk factors, genetic profile, medical history, and other relevant characteristics. This approach aims to provide more targeted and effective screening recommendations, thereby improving the early detection and management of colorectal cancer.
For the treatment and diagnosis of colorectal cancer, the United States and Canada have a well-structured healthcare system. The region's market is anticipated to increase due to factors like the increasing colorectal cancer prevalence rate, rising research funding, and rising market innovations by significant players. Also, according to the same source, in the United States, approximately nine out of ten people with colorectal cancer who are diagnosed early and treated appropriately are still alive five years later. The regional market is expected to rise due to the high prevalence of colorectal cancer and the rising need for screening.
The US market dominated the North America Colorectal Cancer Screening Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $6.6 billion by 2030. The Canada market is poised to grow at a CAGR of 6.6% during (2023 - 2030). Additionally, The Mexico market is would register a CAGR of 5.7% during (2023 - 2030).
Based on Type, the market is segmented into Colonoscopy, Stool-based (Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), and Stool-DNA Test), and Others. Based on End-user, the market is segmented into Government, Energy, Defense, Agriculture & Forestry, Media & Entertainment, Civil Engineering & Archaeology, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Colorectal Cancer Screening Market is Projected to reach USD 22.2 Billion by 2030, at a CAGR of 4.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novigenix SA, Eiken Chemical Co., Ltd., Clinical Genomics Pathology, Inc., Exact Sciences Corporation, Epigenomics AG, BioMerieux S.A., Olympus Corporation, Sysmex Corporation, Fujifilm Holdings Corporation, and Siemens Healthineers AG (Siemens AG).
Scope of the Study
Market Segments Covered in the Report:
By Type
- Fecal Immunochemical Test (FIT)
- Fecal Occult Blood Test (FOBT)
- Stool-DNA Test
By End-user
- Hospitals & Clinics
- Clinical Laboratories
- Diagnostic Imaging Centres
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Novigenix SA
- Eiken Chemical Co., Ltd.
- Clinical Genomics Pathology, Inc.
- Exact Sciences Corporation
- Epigenomics AG
- BioMerieux S.A.
- Olympus Corporation
- Sysmex Corporation
- Fujifilm Holdings Corporation
- Siemens Healthineers AG (Siemens AG)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Colorectal Cancer Screening Market, by Type
1.4.2 North America Colorectal Cancer Screening Market, by End-user
1.4.3 North America Colorectal Cancer Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Jul – 2022, Dec) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. North America Colorectal Cancer Screening Market by Type
5.1 North America Colonoscopy Market by Country
5.2 North America Stool-based Market by Country
5.3 North America Colorectal Cancer Screening Market by Stool-based Type
5.3.1 North America Fecal Immunochemical Test (FIT) Market by Country
5.3.2 North America Fecal Occult Blood Test (FOBT) Market by Country
5.3.3 North America Stool-DNA Test Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Colorectal Cancer Screening Market by End-user
6.1 North America Hospitals & Clinics Market by Country
6.2 North America Clinical Laboratories Market by Country
6.3 North America Diagnostic Imaging Centres Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Colorectal Cancer Screening Market by Country
7.1 US Colorectal Cancer Screening Market
7.1.1 US Colorectal Cancer Screening Market by Type
7.1.1.1 US Colorectal Cancer Screening Market by Stool-based Type
7.1.2 US Colorectal Cancer Screening Market by End-user
7.2 Canada Colorectal Cancer Screening Market
7.2.1 Canada Colorectal Cancer Screening Market by Type
7.2.1.1 Canada Colorectal Cancer Screening Market by Stool-based Type
7.2.2 Canada Colorectal Cancer Screening Market by End-user
7.3 Mexico Colorectal Cancer Screening Market
7.3.1 Mexico Colorectal Cancer Screening Market by Type
7.3.1.1 Mexico Colorectal Cancer Screening Market by Stool-based Type
7.3.2 Mexico Colorectal Cancer Screening Market by End-user
7.4 Rest of North America Colorectal Cancer Screening Market
7.4.1 Rest of North America Colorectal Cancer Screening Market by Type
7.4.1.1 Rest of North America Colorectal Cancer Screening Market by Stool-based Type
7.4.2 Rest of North America Colorectal Cancer Screening Market by End-user
Chapter 8. Company Profiles
8.1 Novigenix SA
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Eiken Chemical Co., Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.3 Clinical Genomics Pathology, Inc.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.3 SWOT Analysis
8.4 Exact Sciences Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.6 SWOT Analysis
8.5 Epigenomics AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 BioMerieux S.A.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Olympus Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.7.5.3 Acquisition and Mergers:
8.7.6 SWOT Analysis
8.8 Sysmex Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Siemens Healthineers AG (Siemens AG)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.4.1 Acquisition and Mergers:
8.9.5 SWOT Analysis
8.10. Fujifilm Holdings Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
8.10.5.3 Geographical Expansions:
8.10.6 SWOT Analysis
TABLE 1 North America Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 2 North America Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Colorectal Cancer Screening Market
TABLE 4 Product Launches And Product Expansions– Colorectal Cancer Screening Market
TABLE 5 Acquisition and Mergers– Colorectal Cancer Screening Market
TABLE 6 Geographical Expansions- Colorectal Cancer Screening Market
TABLE 7 North America Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 8 North America Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 9 North America Colonoscopy Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Colonoscopy Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Stool-based Market by Country, 2019 - 2022, USD Million
TABLE 12 North America Stool-based Market by Country, 2023 - 2030, USD Million
TABLE 13 North America Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 14 North America Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 15 North America Fecal Immunochemical Test (FIT) Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Fecal Immunochemical Test (FIT) Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Fecal Occult Blood Test (FOBT) Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Fecal Occult Blood Test (FOBT) Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Stool-DNA Test Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Stool-DNA Test Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 24 North America Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 25 North America Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
TABLE 27 North America Clinical Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Clinical Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 29 North America Diagnostic Imaging Centres Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Diagnostic Imaging Centres Market by Country, 2023 - 2030, USD Million
TABLE 31 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 32 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 33 North America Colorectal Cancer Screening Market by Country, 2019 - 2022, USD Million
TABLE 34 North America Colorectal Cancer Screening Market by Country, 2023 - 2030, USD Million
TABLE 35 US Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 36 US Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 37 US Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 38 US Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 39 US Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 40 US Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 41 US Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 42 US Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 43 Canada Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 44 Canada Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 45 Canada Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 46 Canada Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 47 Canada Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 48 Canada Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 49 Canada Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 50 Canada Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 51 Mexico Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 52 Mexico Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 53 Mexico Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 54 Mexico Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 55 Mexico Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 56 Mexico Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 57 Mexico Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 58 Mexico Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 59 Rest of North America Colorectal Cancer Screening Market, 2019 - 2022, USD Million
TABLE 60 Rest of North America Colorectal Cancer Screening Market, 2023 - 2030, USD Million
TABLE 61 Rest of North America Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
TABLE 62 Rest of North America Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
TABLE 63 Rest of North America Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
TABLE 64 Rest of North America Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
TABLE 65 Rest of North America Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
TABLE 66 Rest of North America Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
TABLE 67 Key Information – Novigenix SA
TABLE 68 Key Information – Eiken Chemical Co., Ltd.
TABLE 69 Key Information – Clinical Genomics Pathology, Inc.
TABLE 70 Key Information – Exact Sciences Corporation
TABLE 71 Key Information – Epigenomics AG
TABLE 72 Key Information – BioMerieux S.A.
TABLE 73 Key Information – Olympus Corporation
TABLE 74 Key Information – Sysmex Corporation
TABLE 75 Key Information – Siemens Healthineers AG
TABLE 76 Key Information – Fujifilm Holdings Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Colorectal Cancer Screening Market, 2019 - 2030, USD Million
FIG 3 Key Impacting Factors Colorectal Cancer Screening Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Mergers & Acquisition: 2019, Jul – 2022, Dec) Leading Players
FIG 7 Porter’s Five Forces Analysis – Colorectal Cancer Screening Market
FIG 8 North America Colorectal Cancer Screening Market share by Type, 2022
FIG 9 North America Colorectal Cancer Screening Market share by Type, 2030
FIG 10 North America Colorectal Cancer Screening Market by Type, 2019 - 2030, USD Million
FIG 11 North America Colorectal Cancer Screening Market share by End-user, 2022
FIG 12 North America Colorectal Cancer Screening Market share by End-user, 2030
FIG 13 North America Colorectal Cancer Screening Market by End-user, 2019 - 2030, USD Million
FIG 14 North America Colorectal Cancer Screening Market share by Country, 2022
FIG 15 North America Colorectal Cancer Screening Market share by Country, 2030
FIG 16 North America Colorectal Cancer Screening Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Novigenix SA
FIG 18 SWOT Analysis: Clinical Genomics Pathology, Inc.
FIG 19 SWOT Analysis: Exact Sciences Corporation
FIG 20 SWOT Analysis: Epigenomics AG
FIG 21 SWOT Analysis: BioMerieux S.A.
FIG 22 Recent strategies and developments: Olympus Corporation
FIG 23 SWOT Analysis: Olympus Corporation
FIG 24 SWOT Analysis: Sysmex Corporation
FIG 25 SWOT Analysis: Siemens Healthineers AG
FIG 26 Recent strategies and developments: Fujifilm Holdings Corporation
FIG 27 SWOT Analysis: Fujifilm Holdings Corporation